Caribou Accounts Payable from 2010 to 2024

CRBU Stock  USD 2.02  0.04  2.02%   
Caribou Biosciences Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 2.1 M in 2024. Accounts Payable is the amount Caribou Biosciences owes to suppliers or vendors for products or services received but not yet paid for. It represents Caribou Biosciences' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
3.1 M
Current Value
2.1 M
Quarterly Volatility
569.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Caribou Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caribou Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 202.7 K, Net Interest Income of 119.7 K or Interest Income of 126.5 K, as well as many indicators such as Price To Sales Ratio of 11.65, Dividend Yield of 0.0 or PTB Ratio of 1.09. Caribou financial statements analysis is a perfect complement when working with Caribou Biosciences Valuation or Volatility modules.
  
Check out the analysis of Caribou Biosciences Correlation against competitors.
For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.

Latest Caribou Biosciences' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Caribou Biosciences over the last few years. An accounting item on the balance sheet that represents Caribou Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Caribou Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Caribou Biosciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caribou Biosciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

Caribou Accounts Payable Regression Statistics

Arithmetic Mean2,558,003
Geometric Mean2,490,267
Coefficient Of Variation22.26
Mean Deviation271,599
Median2,537,000
Standard Deviation569,377
Sample Variance324.2B
Range2.8M
R-Value(0.01)
Mean Square Error349.1B
R-Squared0.000035
Significance0.98
Slope(752.57)
Total Sum of Squares4.5T

Caribou Accounts Payable History

20242.1 M
20233.1 M
20221.1 M
2021M
20202.6 M

About Caribou Biosciences Financial Statements

Caribou Biosciences shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Caribou Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Caribou Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Caribou Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable3.1 M2.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.